1-6 of 6
Malathi Hari
Close
Sort by
Journal Articles

Proteomic Profiling of Multiple Myeloma Using iTRAQ Labeling Followed by Multidimensional Liquid Chromatography and Tandem Mass Spectrometry.

Dominik Dytfeld, MD, PhD, Malathi Hari, PhD, John Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4865.
https://doi.org/10.1182/blood.V114.22.4865.4865
Published: 2009
Journal Articles

WP-1130 Induces Apoptosis in Multiple Myeloma Cells by Inactivation of Jak2 and Syk Tyrosine Kinases Via a Novel Mechanism of Selective Protein Trafficking

Daniel Lebovic, Vaibhav Kapuria, Malathi Hari, Moshe Talpaz, Andrzej Jakubowiak, Nicholas Donato
Journal: Blood
Blood (2008) 112 (11): 2661.
https://doi.org/10.1182/blood.V112.11.2661.2661
Published: 2008
Journal Articles

Elimination of CD20-Expressing Cells in Multiple Myeloma by Iodine I-131 Tositumomab (Bexxar ® ) Correlates with Response to Therapy

Andrzej J. Jakubowiak, MD, PhD, Malathi Hari, PhD, Tara Kendall, PA, Yasser Khaled, MD, Shin Mineishi, MD, Ammar Al-Zoubi, MD, Mark S. Kaminski, MD, Ivan Maillard, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5176.
https://doi.org/10.1182/blood.V112.11.5176.5176
Published: 2008
Journal Articles

Serum Free Light Chain Analysis Improves Monitoring of Multiple Myeloma Patients Receiving First-Line Therapy with the Combination of Velcade, Doxil, and Dexamethasone (VDD).

Daniel Lebovic, MD, Tara Kendall, PA-C, Christine Brozo, PA-C, Amanda McAllister, BS, Malathi Hari, PhD, Sairah Alvi, PhD, Ewan J.D. Robson, PhD, Andrzej J. Jakubowiak, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2736.
https://doi.org/10.1182/blood.V110.11.2736.2736
Published: 2007
Journal Articles

Gene Expression Profiles (GEP) To Predict at Least Very Good Partial Response to Velcade, Doxil, and Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma.

Malathi Hari, James MacDonald, Judah Friedman, Tara Kendall, George Mulligan, Andrzej Jakubowiak
Journal: Blood
Blood (2007) 110 (11): 1489.
https://doi.org/10.1182/blood.V110.11.1489.1489
Published: 2007
Journal Articles

Targeted Therapy Against Clonogenic Myeloma Cells with Iodine I-131 Tositumomab (Bexxar™).

Andrzej Jakubowiak, Malathi Hari, Ammar Al-Zoubi, Tara Kendall, Yasser Khaled, Shin Mineishi, Mark Kaminski
Journal: Blood
Blood (2007) 110 (11): 4796.
https://doi.org/10.1182/blood.V110.11.4796.4796
Published: 2007